Bain Capital Specialty Finance Inc
NYSE:BCSF
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
14.93
17.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Bain Capital Specialty Finance Inc
Bain Capital Specialty Finance Inc
Cash & Cash Equivalents
Bain Capital Specialty Finance Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bain Capital Specialty Finance Inc
NYSE:BCSF
|
Cash & Cash Equivalents
$30.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Ameriprise Financial Inc
NYSE:AMP
|
Cash & Cash Equivalents
$10.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
|
KKR & Co Inc
NYSE:KKR
|
Cash & Cash Equivalents
$15.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
34%
|
CAGR 10-Years
17%
|
|
|
BlackRock Inc
NYSE:BLK
|
Cash & Cash Equivalents
$10.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
5%
|
|
|
Bank of New York Mellon Corp
NYSE:BK
|
Cash & Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Blackstone Inc
NYSE:BX
|
Cash & Cash Equivalents
$2.5B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
0%
|
|
Bain Capital Specialty Finance Inc
Glance View
Bain Capital Specialty Finance, Inc. operates as a development stage company, which intends to focus on senior investments with a first or second lien on collateral and strong structures and documentation, intended to protect the lender. The company is headquartered in Boston, Massachusetts and currently employs 0 full-time employees. The company went IPO on 2018-11-15. The firm is focused on generating income and to a lesser extent, capital appreciation through direct originations of secured debt, including first lien, first lien/last-out, unitranche and second lien debt, investments in strategic joint ventures, equity investments and to a lesser extent, corporate bonds. Its primary focus is capitalizing on opportunities within Bain Capital Credit's Senior Direct Lending Strategy. The company is focused on providing risk-adjusted returns and income to its stockholders by investing primarily in middle-market companies with between 10 million dollars and 150 million dollars in annual earnings before interest, taxes, depreciation and amortization (EBITDA). The company may also invest in mezzanine debt and other junior securities, including common and preferred equity on an opportunistic basis. The company is managed by BCSF Advisors, LP.
See Also
What is Bain Capital Specialty Finance Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
30.5m
USD
Based on the financial report for Sep 30, 2024, Bain Capital Specialty Finance Inc's Cash & Cash Equivalents amounts to 30.5m USD.
What is Bain Capital Specialty Finance Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-16%
Over the last year, the Cash & Cash Equivalents growth was -62%. The average annual Cash & Cash Equivalents growth rates for Bain Capital Specialty Finance Inc have been -5% over the past three years , -16% over the past five years .
You don't have any saved screeners yet
